Reconciled ClinicalTrials.gov v2 Protocol Specification
| Protocol Field | Verified Registry Value |
|---|---|
| NCT Identifier | NCT06745882 |
| Consolidated Lead Sponsor | H. Lee Moffitt Cancer Center and Research Institute |
| Therapeutic Condition Cohort | Oncology and Hematology |
| Clinical Trial Phase | Phase II |
| Overall Recruitment Status | RECRUITING |
| Registered Enrollment | 318 participants (ESTIMATED) |
| Registered Start Date | 2025-06-13 |
| WhyStopped Classification | Not Stopped |
Named U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Site Profile |
|---|---|---|
| Moffitt Cancer Center | Tampa, FL | Open Hospital Dossier -> |
| University of Maryland/Greenebaum Cancer Center | Baltimore, MD | Open Hospital Dossier -> |
| Sinai Hospital of Baltimore | Baltimore, MD | Open Hospital Dossier -> |
| Johns Hopkins Hospital and Kimmel Cancer Center | Baltimore, MD | Open Hospital Dossier -> |
Related Filings Across Meru Platforms
Verified cross-ledger federal filings for Moffitt Cancer Center across sibling Meru public-data platforms.
Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.